Pall banner

ABOUT PALL BIOTECH

   

Pall Biotech Sciences Delivers Total Solutions for Today’s Drug Researcher and Manufacturer

Pall Biotech, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule drugs. The unmatched portfolio of traditional and single-use products is backed by custom service support and is both scalable and easily integrated to support processes from R&D through to commercial phases of production, including formulation/filling. As a core driver of the continuous bioprocessing movement, Pall Life Sciences has remained focused on delivering innovative semi- and fully continuous solutions, with the goal of continuously improving bioprocesses for a safer, healthier future.

A Tailored Portfolio

Pall Biotech’s comprehensive portfolio of traditional and single-use upstream, downstream and viral filtration technologies is enhanced by a global network of ISO9001 certified manufacturing facilities, and a full range of Scientific and Laboratory Services (SLS), technical process and validation support.

The portfolio has been designed to offer easily integrated, scalable solutions to support the evolving needs of global researchers and manufacturers of:

  • Biopharmaceuticals/Large Molecule Drugs
  • Cell and Gene Therapies
  • Vaccines and Plasma
  • Active Pharmaceutical Ingredients (APIs)  

The comprehensive portfolio of products includes:

  • Bioreactors
  • Capsules
  • Cartridges and Elements
  • Chromatography
  • Filter Housings
  • Instruments
  • Membranes and Materials
  • Microcarriers
  • Sterile Connectors
  • Mixers
  • Service and Technical Support
  • Sheet Filters and Modules
  • Sterilizable Packaging
  • Syringe Filters
  • Systems, Accessories and Components

Customizable Support Services and Capabilities

The Pall Biotech team delivers industry leading process validation and technical support to customers as a daily standard, with assurance that global regulatory compliance rules are understood, and met (or exceeded). Additionally, the team offers access to customizable support service add-ons that help customers overcome challenges and meet goals more efficiently.

With more than 30 years of established service, the Pall Life Sciences Scientific and Laboratory Services (SLS) group is an established authority in fluid management. SLS scientists, engineers, and technicians work in state-of-the-art facilities in the Americas, Europe, Australia and Asia to deliver compatibility studies, extractable and leachable studies, particulate validation and more, via:

  • SLS Centers of Excellence for state-of the-art analytical biopharma testing services
  • SLS Laboratory Centers for advanced laboratory testing, failure analysis and validation services
  • SLS Customer Support Centers for small lab(s)/basic testing

Pall Biotech also features Pall Advanced Separation Systems (PASS) facilities across the globe to deliver excellence in bioprocess engineering and project execution, providing customers with invaluable resources that enable:

  • Automated operations
  • Linear scale-up
  • Streamlined processes

 

PALL WEBINARS

Continuous Chromatography: The Effect of the Number of Process Columns on Specific Productivity and Binding Capacity Continuous Chromatography: The Effect of the Number of Process Columns on Specific Productivity and Binding Capacity

Address optimal configuration of a multi-column continuous chromatography (MCC) system, with insight into the impact antibody titer has on the number of chromatography columns required to optimize productivity of a MCC process.

Advancing Continuous Concentration with Patented Single-Pass Tangential Flow Filtration Advancing Continuous Concentration with Patented Single-Pass Tangential Flow Filtration

Review simplified continuous filtration, particularly for UF/DF, with a look into our exclusive license to patents in the field of single-pass tangential flow filtration (SPTFF), which enables continuous filtration without recirculation at several stages of a continuous bioprocess.

Mitigating Continuous Bioprocessing Technology and Regulatory Challenges Mitigating Continuous Bioprocessing Technology and Regulatory Challenges

Examine common regulatory challenges and areas of uncertainty in the implementation of continuous bioprocessing, and understand practical, total solutions.

Alignment To Standardized Extractables Testing, Facilitating Single-Use Adoption Alignment To Standardized Extractables Testing, Facilitating Single-Use Adoption

Addressing the concerns regarding limiting the rapid adoption and implementation of single-use technology has centered on standardizing single-use component extractables data packages to be used for end user risk assessments.

A Versatile Solution For Host Cell Proteins (HCPs) and Aggregates Removal For mAbs Purification A Versatile Solution For Host Cell Proteins (HCPs) and Aggregates Removal For mAbs Purification

Discover how you enhance the removal of HCPs and aggregates during mAbs production with versatile solutions that deliver over a broad range of conductivity and pH to fit with any mAb, while using a platform process adaptable to both batch and continuous processing.

More From Pall Webinars

CONTACT INFORMATION

Pall Biotech

20 Walkup Drive

Westborough, MA 01581

UNITED STATES

Phone: 1.508.871.5400